EP0942748A4 - Env-glycoprotein vaccine for protection of htlv-i and -ii infection - Google Patents

Env-glycoprotein vaccine for protection of htlv-i and -ii infection

Info

Publication number
EP0942748A4
EP0942748A4 EP97935044A EP97935044A EP0942748A4 EP 0942748 A4 EP0942748 A4 EP 0942748A4 EP 97935044 A EP97935044 A EP 97935044A EP 97935044 A EP97935044 A EP 97935044A EP 0942748 A4 EP0942748 A4 EP 0942748A4
Authority
EP
European Patent Office
Prior art keywords
htlv
env
infection
protection
glycoprotein vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97935044A
Other languages
German (de)
French (fr)
Other versions
EP0942748A1 (en
Inventor
William W Hall
Hidehiro Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Publication of EP0942748A1 publication Critical patent/EP0942748A1/en
Publication of EP0942748A4 publication Critical patent/EP0942748A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
EP97935044A 1996-07-22 1997-07-22 Env-glycoprotein vaccine for protection of htlv-i and -ii infection Withdrawn EP0942748A4 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US681054 1984-12-13
US68105496A 1996-07-22 1996-07-22
US89789897A 1997-07-21 1997-07-21
US897898 1997-07-21
PCT/US1997/012776 WO1998003197A1 (en) 1996-07-22 1997-07-22 Env-glycoprotein vaccine for protection of htlv-i and -ii infection

Publications (2)

Publication Number Publication Date
EP0942748A1 EP0942748A1 (en) 1999-09-22
EP0942748A4 true EP0942748A4 (en) 2004-12-08

Family

ID=27102582

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97935044A Withdrawn EP0942748A4 (en) 1996-07-22 1997-07-22 Env-glycoprotein vaccine for protection of htlv-i and -ii infection

Country Status (4)

Country Link
EP (1) EP0942748A4 (en)
JP (1) JP2002513381A (en)
CA (1) CA2262007A1 (en)
WO (1) WO1998003197A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777044B2 (en) 2003-05-02 2017-10-03 Centre National De La Recherche Scientifique (Cnrs) GLUT-1 as a receptor for HTLV envelopes and its uses
EP1648926B1 (en) 2003-05-02 2013-07-03 Centre National De La Recherche Scientifique (Cnrs) Glut-1 as a receptor for htlv envelopes and its uses
PT2172211E (en) 2008-10-01 2015-03-09 Immatics Biotechnologies Gmbh Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers
CN102326079B (en) 2009-01-09 2015-04-15 国家科研中心 New receptor binding ligands, their use in the detection of cells with biological interest

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743678A (en) * 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus
US5516632A (en) * 1988-02-08 1996-05-14 Duke University Synthetic peptides

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KAWAMURA NAOYUKI: "Production of HTLV-II env protein and its suppressive effect on infection", HOKKAIDO JOURNAL OF MEDICAL SCIENCE, vol. 70, no. 4, 1995, pages 635 - 647, XP009033859, ISSN: 0367-6102 *
LI QI-XIANG ET AL: "Rapid generation of antibodies against the HTLV-II external envelope protein by growth of mouse plasmacytomas in SCID mice", VIROLOGY, vol. 214, no. 2, 1995, pages 680 - 684, XP001182556, ISSN: 0042-6822 *
See also references of WO9803197A1 *
WANG BIN ET AL: "Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion", AIDS RESEARCH AND HUMAN RETROVIRUSES, NEW YORK, NY, US, vol. 9, no. 9, September 1993 (1993-09-01), pages 849 - 860, XP000925933, ISSN: 0889-2229 *

Also Published As

Publication number Publication date
EP0942748A1 (en) 1999-09-22
JP2002513381A (en) 2002-05-08
CA2262007A1 (en) 1998-01-29
WO1998003197A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
IL132582A0 (en) Polyethylene glycol-interferon alpha conjugates for therapy of infection
EP0751786A4 (en) Urease-based vaccine and treatment for helicobacter infection
HUP9903947A3 (en) Purification of neurotrophins
EP0738516A4 (en) External preparation for skin protection
IT1283630B1 (en) PROCESS FOR THE PREPARATION OF EP (D) M ELASTOMERIC COPOLYMERS
HUP9601466A2 (en) Adjuvants for viral vaccines
HUP9601462A2 (en) Adjuvants for viral vaccines
EP0868196A4 (en) Synthetic vaccine for protection against human immunodeficiency virus infection
AU1750497A (en) Compounds capable of inhibiting hiv-1 infection
EP0942748A4 (en) Env-glycoprotein vaccine for protection of htlv-i and -ii infection
IL130125A0 (en) Preparation of N-substituted 3-hydroxypyrazoles
ZA9711565B (en) Vaccine
ZA96722B (en) Combination therapy for hiv infection
AU4602897A (en) Method for treatment of immunodeficiency virus infection
GB9615022D0 (en) Vaccine preparations
HU9603567D0 (en) Combination therapy for hiv infection
AU3807397A (en) Env-glycoprotein vaccine for protection of htlv-i and -ii infection
GB2304575B (en) Protection of trees
GB9425604D0 (en) Peptides effective for diagnsis of hepatitis C infection
IL115197A0 (en) Vaccine preparations
GB9615314D0 (en) Inhibition of respiratory infection
AU1891795A (en) Phenylalkylamino derivatives of condensed carbapenemes
FI972182A0 (en) Protection for minor surgical procedures
GB9424145D0 (en) Detection of bacterial infection

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20041022

17Q First examination report despatched

Effective date: 20050223

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20050201